The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of IgVH mutational status in patients with chronic lymphocytic leukemia with isolated good and intermidiate risk genetic aberrations.
 
Jose David Sandoval-Sus
No Relationships to Disclose
 
Samir Dalia
No Relationships to Disclose
 
Chetasi Talati
No Relationships to Disclose
 
Bijal D. Shah
No Relationships to Disclose
 
Celeste M. Bello
No Relationships to Disclose
 
Jeffrey E. Lancet
Consulting or Advisory Role - Amgen; Asterias Biotherapeutics; Baxalta; Boehringer Ingelheim; Celator; Celgene; Celgene; KaloBios; Karyopharm Therapeutics; Novartis; Shire
Research Funding - Celgene (Inst); Pfizer (Inst)
 
Paul A. Chervenick
No Relationships to Disclose
 
Frederick Lundry Locke
No Relationships to Disclose
 
Mohamed Kharfan-Dabaja
No Relationships to Disclose
 
Eduardo M. Sotomayor
No Relationships to Disclose
 
Lubomir Sokol
No Relationships to Disclose
 
Julio C. Chavez
No Relationships to Disclose
 
Javier Pinilla-Ibarz
No Relationships to Disclose